PDGFRA and systemic mastocytosis: Our patient showed an evolution from <i>KIT</i> mutated indolent SM to a myeloid neoplasm with <i>PDGFRA</i> rearrangement; when the eosinophilic component expanded, a regression of the MC counterpart was observed.